Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors
Kumarasinghe, Gayathri, MBBS, FRACP, Lavee, Orly, MBBS, FRACP, Parker, Andrew, MBBS, FRCPA, Nivison-Smith, Ian, MAppStat, PhD, Milliken, Samuel, MBBS, FRACP, Dodds, Anthony, MBBS, FRACP, Joseph, Joanne, MBBS, FRACP, Fay, Keith, MBBS, FRACP, Ma, David D., MBBS, FRACP, Malouf, Monique, MBBS, FRACP, Plit, Marshall, MBBS, FRACP, Havryk, Adrian, FRACP, PhD, Keogh, Ann M., MBBS, FRACP, Hayward, Christopher S., MBBS, FRACP, Kotlyar, Eugene, MBBS, FRACP, Jabbour, Andrew, FRACP, PhD, Glanville, Allan R., MBBS, FRACP, Macdonald, Peter S., FRACP, PhD, Moore, John J., MBBS, FRACP, FRCPA
Published in The Journal of heart and lung transplantation (01.11.2015)
Published in The Journal of heart and lung transplantation (01.11.2015)
Get full text
Journal Article
Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14
Hertzberg, Mark, Gandhi, Maher K, Trotman, Judith, Butcher, Belinda, Taper, John, Johnston, Amanda, Gill, Devinder, Ho, Shir-Jing, Cull, Gavin, Fay, Keith, Chong, Geoff, Grigg, Andrew, Lewis, Ian D, Milliken, Sam, Renwick, William, Hahn, Uwe, Filshie, Robin, Kannourakis, George, Watson, Anne-Marie, Warburton, Pauline, Wirth, Andrew, Seymour, John F, Hofman, Michael S, Hicks, Rodney J
Published in Haematologica (Roma) (01.02.2017)
Published in Haematologica (Roma) (01.02.2017)
Get full text
Journal Article
Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy
Hughes, Timothy P., Branford, Susan, White, Deborah L., Reynolds, John, Koelmeyer, Rachel, Seymour, John F., Taylor, Kerry, Arthur, Chris, Schwarer, Anthony, Morton, James, Cooney, Julian, Leahy, Michael F., Rowlings, Philip, Catalano, John, Hertzberg, Mark, Filshie, Robin, Mills, Anthony K., Fay, Keith, Durrant, Simon, Januszewicz, Henry, Joske, David, Underhill, Craig, Dunkley, Scott, Lynch, Kevin, Grigg, Andrew
Published in Blood (15.11.2008)
Published in Blood (15.11.2008)
Get full text
Journal Article
Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndrome
Shen, Yandong, Coyle, Luke, Kerridge, Ian, Stevenson, William, Arthur, Christopher, McKinlay, Naomi, Fay, Keith, Ward, Christopher, Greenwood, Matthew, Best, Oliver Giles, Solterbeck, Ann, Guminski, Alexander, Shumack, Stephen, Mulligan, Stephen P.
Published in EJHaem (01.02.2022)
Published in EJHaem (01.02.2022)
Get full text
Journal Article
P1078: MOSUNETUZUMAB DEMONSTRATES DURABLE RESPONSES IN PATIENTS WITH RELAPSED AND/OR REFRACTORY FOLLICULAR LYMPHOMA WHO HAVE RECEIVED ≥2 PRIOR THERAPIES: UPDATED ANALYSIS OF A PIVOTAL PHASE II STUDY
Sehn, Laurie H., Bartlett, Nancy L., Matasar, Matthew, Schuster, Stephen J., Assouline, Sarit, Kuruvilla, John, Shadman, Mazyar, Cheah, Chan, Fay, Keith, Ku, Matthew, Nastoupil, Loretta J., Wei, Michael, Yin, Shen, To, Iris, Hu, Nan, Min, Juliana, Penuel, Elicia, Belousov, Anton, Coimbra, Alexandre, Jemaa, Skander, Bender, Brendan, Turner, David, Elizabeth Budde, L.
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Acute life‐threatening cardiovascular toxicity with umbilical cord blood infusion: The role of dextran
Ma, Robert W., Kwan, John M., Ma, David D., Fay, Keith C.
Published in American journal of hematology (01.09.2010)
Published in American journal of hematology (01.09.2010)
Get full text
Journal Article
Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study
Budde, Lihua E, Sehn, Laurie H, Matasar, Matthew, Schuster, Stephen J, Assouline, Sarit, Giri, Pratyush, Kuruvilla, John, Canales, Miguel, Dietrich, Sascha, Fay, Keith, Ku, Matthew, Nastoupil, Loretta, Cheah, Chan Yoon, Wei, Michael C, Yin, Shen, Li, Chi-Chung, Huang, Huang, Kwan, Antonia, Penuel, Elicia, Bartlett, Nancy L
Published in The lancet oncology (01.08.2022)
Published in The lancet oncology (01.08.2022)
Get full text
Journal Article
Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantation
Lindsay, Julian, Sandaradura, Indy, Wong, Kelly, Arthur, Chris, Stevenson, William, Kerridge, Ian, Fay, Keith, Coyle, Luke, Greenwood, Matthew
Published in Journal of antimicrobial chemotherapy (01.12.2017)
Published in Journal of antimicrobial chemotherapy (01.12.2017)
Get full text
Journal Article
FIP1L1::PDGFRA fusion driving three synchronous haematological malignancies
Krigstein, Michael, Menzies, Anna, Fay, Keith, Lukeis, Robyn, Cheung, Karen, Parker, Andrew
Published in Pathology (01.12.2023)
Published in Pathology (01.12.2023)
Get full text
Journal Article
Identification of Respiratory Viral Infection in Hematopoietic Stem Cell Transplant Recipients - Impact on Non Relapse Mortality
Imlay-Gillespie, Louise, Srinivasan, Meera, Wong, Kelly, Arthur, Christopher, Fay, Keith, MD, Kerridge, Ian, Stevenson, William, Greenwood, Matthew
Published in Biology of blood and marrow transplantation (01.02.2015)
Published in Biology of blood and marrow transplantation (01.02.2015)
Get full text
Journal Article
Dose Adjusted R-EPOCH Does Not Improve Outcomes in High Grade B Cell Lymphoma with Double Expressor Status or Gain of MYC/BCL2
Hardefeldt, Prue, Moore, John, Milliken, Sam, Fay, Keith, Orly, Lavee, Mayson, Eleni, Withers, Barbara, Hamad, Nada
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Orthotopic Heart Transplantation Followed By Autologous Stem Cell Transplantation in Patients with Cardiac AL Amyloidosis: Results from a Single Centre Prospective Study
Rajasekariah, Harshita, McCaughan, Georgia, Ma, Chun Kei Kris, Gorrie, Natasha, Milliken, Samuel, Ma, David, Fay, Keith, Withers, Barbara, Hamad, Nada, Birch, Samuel, Keogh, Anne, Jabbour, Andrew, Hayward, Christopher, Macdonald, Peter, Moore, John
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Response to Mosunetuzumab in Patients with B-Cell Lymphomas Relapsed or Refractory after CAR-T Cell Therapy Is Associated with Changes in Lymphocyte Counts
Chong, Elise A., Penuel, Elicia, Bartlett, Nancy L., Bosch, Francesc, Budde, L. Elizabeth, Fay, Keith, Flinn, Ian W., Goy, Andre, Kumar, Anita, Lundberg, Rachel, Napier, Ellen B., Nastoupil, Loretta J., Shadman, Mazyar, Wei, Michael C., Wu, Mei, Yin, Shen, Chong, Emeline R., Schuster, Stephen J.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Mosunetuzumab Monotherapy Continues to Demonstrate Durable Responses in Patients with Relapsed and/or Refractory Follicular Lymphoma after ≥2 Prior Therapies: 3-Year Follow-up from a Pivotal Phase II Study
Schuster, Stephen J., Sehn, Laurie H., Bartlett, Nancy L., Matasar, Matthew, Assouline, Sarit, Giri, Pratyush, Kuruvilla, John, Shadman, Mazyar, Cheah, Chan Y., Dietrich, Sascha, Fay, Keith, Ku, Matthew, Nastoupil, Loretta J., Wei, Michael C., Yin, Shen, To, Iris, Huang, Jiangeng, Kwan, Antonia, Penuel, Elicia, Budde, L. Elizabeth
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
037 Post-transplant lymphoproliferative disorder in skeletal muscle arising seven years after allogeneic stem cell transplant
Powell, Alice, Sy, Joanne, Barnett, Yael, Mosalski, Simon, Brew, Bruce, Fay, Keith, Tomlinson, Susan
Published in Journal of neurology, neurosurgery and psychiatry (01.06.2018)
Published in Journal of neurology, neurosurgery and psychiatry (01.06.2018)
Get full text
Journal Article
Outcomes for Allogeneic Stem Cell Transplantation in Secondary AML Are Inferior to De Novo AML and Are Independent of the Disease Risk Index
Perram, Jacinta, Mayson, Eleni, Tang, Catherine, Tran, Steven, Aarons, Donna, Dodds, Anthony J, Fay, Keith, Hamad, Nada, Ma, David, Milliken, Sam, Withers, Barbara, Greenwood, Matthew, Stevenson, William S, Arthur, Christopher Kevin, Kerridge, Ian H, Moore, John
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Subcutaneous Mosunetuzumab Is Active with a Manageable Safety Profile in Patients (pts) with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphomas (B-NHLs): Updated Results from a Phase I/II Study
Budde, Elizabeth L., Bartlett, Nancy L., Giri, Pratyush, Schuster, Stephen J., Assouline, Sarit, Yoon, Sung-Soo, Fay, Keith, Matasar, Matthew J., Gutierrez, Norma C., Marlton, Paula, Dreyling, Martin, Yoon, Dok Hyun, Hess, Georg, Radford, John, Wiebking, Volker, Yin, Shen, Cybulski, Eva, Turner, David C., Huang, Huang, Zhou, Mingzhu, Penuel, Elicia, Wei, Michael C., Sehn, Laurie H.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Mosunetuzumab Monotherapy Demonstrates Durable Efficacy with a Manageable Safety Profile in Patients with Relapsed/Refractory Follicular Lymphoma Who Received ≥2 Prior Therapies: Updated Results from a Pivotal Phase II Study
Bartlett, Nancy L., Sehn, Laurie H., Matasar, Matthew J., Schuster, Stephen J., Assouline, Sarit, Giri, Pratyush, Kuruvilla, John, Canales, Miguel, Dietrich, Sascha, Fay, Keith, Ku, Matthew, Nastoupil, Loretta J., Wei, Michael C., Yin, Shen, To, Iris, Huang, Huang, Min, Juliana, Penuel, Elicia, Budde, L. Elizabeth
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Phase 2 study of parsaclisib (INCB050465), a highly selective, next-generation PI3Kδ inhibitor, in relapsed or refractory diffuse large B-cell lymphoma (CITADEL-202)
Coleman, Morton, Belada, David, Casasnovas, René-Olivier, Gressin, Rémy, Lee, Hui-Peng, Mehta, Amitkumar, Munoz, Javier, Verhoef, Gregor, Corrado, Claudia, DeMarini, Douglas J., Zhao, Wanying, Li, Jia, Fay, Keith
Published in Leukemia & lymphoma (28.01.2021)
Published in Leukemia & lymphoma (28.01.2021)
Get full text
Journal Article
Prolonged administration of low-dose cytarabine and thioguanine in elderly patients with acute myeloid leukaemia (AML) achieves high complete remission rates and prolonged survival
Arthur, Christopher, Jeffrey, Anthony, Yip, Eva, Katsioulas, Vicki, Nalpantidis, Anastasios, Kerridge, Ian, Greenwood, Matthew, Coyle, Luke, Mackinlay, Naomi, Fay, Keith, Enjeti, Anoop, Shortt, Jake, Stevenson, William
Published in Leukemia & lymphoma (20.03.2020)
Published in Leukemia & lymphoma (20.03.2020)
Get full text
Journal Article